These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21784641)

  • 41. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae.
    Trotter CL; McVernon J; Ramsay ME; Whitney CG; Mulholland EK; Goldblatt D; Hombach J; Kieny MP;
    Vaccine; 2008 Aug; 26(35):4434-45. PubMed ID: 18617296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A feasibility study of controlled human infection with Streptococcus pneumoniae in Malawi.
    Morton B; Burr S; Chikaonda T; Nsomba E; Manda-Taylor L; Henrion MYR; Banda NP; Rylance J; Ferreira DM; Jambo K; Gordon SB;
    EBioMedicine; 2021 Oct; 72():103579. PubMed ID: 34571365
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of antibodies against pneumococcal proteins alpha-enolase, immunoglobulin A1 protease, streptococcal lipoprotein rotamase A, and putative proteinase maturation protein A in relation to pneumococcal carriage and Otitis Media.
    Adrian PV; Bogaert D; Oprins M; Rapola S; Lahdenkari M; Kilpi T; de Groot R; Käyhty H; Hermans PW
    Vaccine; 2004 Jul; 22(21-22):2737-42. PubMed ID: 15246605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Using the impact of pneumococcal vaccines on nasopharyngeal carriage to aid licensing and vaccine implementation; a PneumoCarr meeting report March 27-28, 2012, Geneva.
    Goldblatt D; Ramakrishnan M; O'Brien K
    Vaccine; 2013 Dec; 32(1):146-52. PubMed ID: 23933374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae.
    Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW
    Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pneumococcal Vaccines.
    Briles DE; Paton JC; Mukerji R; Swiatlo E; Crain MJ
    Microbiol Spectr; 2019 Nov; 7(6):. PubMed ID: 31858954
    [No Abstract]   [Full Text] [Related]  

  • 47. Nasopharyngeal pneumococcal carriage after combined pneumococcal conjugate and polysaccharide vaccination in children with a history of recurrent acute otitis media.
    Veenhoven RH; Bogaert D; Schilder AG; Rijkers GT; Uiterwaal CS; Kiezebrink HH; van Kempen MJ; Dhooge IJ; Bruin J; Ijzerman EP; de Groot R; Kuis W; Hermans PW; Sanders EA
    Clin Infect Dis; 2004 Oct; 39(7):911-9. PubMed ID: 15472839
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antipneumococcal vaccine: up date and prospective].
    Caramia G; Pastorelli G
    Minerva Pediatr; 2005 Oct; 57(5):229-41. PubMed ID: 16205607
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pneumococcal nasopharyngeal carriage among infants born to human immunodeficiency virus-infected mothers immunized with pneumococcal polysaccharide vaccine during gestation.
    Almeida Vde C; Negrini BV; Cervi MC; Isaac Mde L; Mussi-Pinhata MM
    Pediatr Infect Dis J; 2011 Jun; 30(6):466-70. PubMed ID: 21200361
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era.
    Onwubiko C; Swiatlo E; McDaniel LS
    J Clin Microbiol; 2008 Nov; 46(11):3621-5. PubMed ID: 18845823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
    Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy.
    Dagan R; Givon-Lavi N; Greenberg D; Fritzell B; Siegrist CA
    J Infect Dis; 2010 May; 201(10):1570-9. PubMed ID: 20384496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Herd immunity alters the conditions for performing dose schedule comparisons: an individual-based model of pneumococcal carriage.
    Yang A; Cai F; Lipsitch M
    BMC Infect Dis; 2019 Mar; 19(1):227. PubMed ID: 30836941
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Recent approaches in vaccine development against Streptococcus pneumoniae.
    Tarahomjoo S
    J Mol Microbiol Biotechnol; 2014; 24(4):215-27. PubMed ID: 25196525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pneumococcal vaccination among adults with chronic respiratory diseases: a historical overview.
    Vila-Corcoles A; Ochoa-Gondar O
    Expert Rev Vaccines; 2012 Feb; 11(2):221-36. PubMed ID: 22309670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Streptococcus pneumoniae: elusive mechanisms of the body's defense systems.
    Bondi T; Canessa C; Lippi F; Iacopelli J; Nieddu F; Azzari C
    J Prev Med Hyg; 2012 Jun; 53(2):89-93. PubMed ID: 23240166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review: current and new generation pneumococcal vaccines.
    Feldman C; Anderson R
    J Infect; 2014 Oct; 69(4):309-25. PubMed ID: 24968238
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of early carriage of Streptococcus pneumoniae on the development of pneumococcal protein-specific cellular immune responses in infancy.
    van den Biggelaar AH; Pomat WS; Phuanukoonnon S; Michael A; Aho C; Nadal-Sims MA; Devitt CJ; Jacoby PA; Hales BJ; Smith WA; Mitchell T; Wiertsema S; Richmond P; Siba P; Holt PG; Lehmann D
    Pediatr Infect Dis J; 2012 Mar; 31(3):243-8. PubMed ID: 22189528
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Next generation protein based Streptococcus pneumoniae vaccines.
    Pichichero ME; Khan MN; Xu Q
    Hum Vaccin Immunother; 2016; 12(1):194-205. PubMed ID: 26539741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design questions for Streptococcus pneumoniae vaccine trials with a colonisation endpoint.
    Auranen K; Rinta-Kokko H; Goldblatt D; Nohynek H; O'Brien KL; Satzke C; Simell B; Tanskanen A; Käyhty H
    Vaccine; 2013 Dec; 32(1):159-64. PubMed ID: 23871614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.